Oppenheimer & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $245K | Sell |
8,888
-1,331
| -13% | -$36.7K | ﹤0.01% | 1423 |
|
2025
Q1 | $290K | Buy |
10,219
+255
| +3% | +$7.23K | ﹤0.01% | 1300 |
|
2024
Q4 | $414K | Sell |
9,964
-27,823
| -74% | -$1.16M | 0.01% | 1137 |
|
2024
Q3 | $2.53M | Sell |
37,787
-5,144
| -12% | -$344K | 0.04% | 476 |
|
2024
Q2 | $5.1M | Buy |
42,931
+2,626
| +7% | +$312K | 0.08% | 270 |
|
2024
Q1 | $4.29M | Buy |
40,305
+8,214
| +26% | +$875K | 0.07% | 307 |
|
2023
Q4 | $3.19M | Sell |
32,091
-12,611
| -28% | -$1.25M | 0.06% | 369 |
|
2023
Q3 | $4.62M | Buy |
44,702
+769
| +2% | +$79.4K | 0.1% | 245 |
|
2023
Q2 | $5.34M | Sell |
43,933
-2,766
| -6% | -$336K | 0.11% | 219 |
|
2023
Q1 | $7.17M | Buy |
46,699
+1,606
| +4% | +$247K | 0.15% | 157 |
|
2022
Q4 | $8.1M | Sell |
45,093
-3,989
| -8% | -$717K | 0.18% | 129 |
|
2022
Q3 | $5.8M | Sell |
49,082
-3,663
| -7% | -$433K | 0.14% | 181 |
|
2022
Q2 | $7.53M | Sell |
52,745
-14,369
| -21% | -$2.05M | 0.16% | 138 |
|
2022
Q1 | $11.6M | Buy |
67,114
+7,316
| +12% | +$1.26M | 0.21% | 94 |
|
2021
Q4 | $15.2M | Sell |
59,798
-8,968
| -13% | -$2.28M | 0.27% | 73 |
|
2021
Q3 | $26.5M | Sell |
68,766
-21,558
| -24% | -$8.3M | 0.5% | 28 |
|
2021
Q2 | $21.2M | Sell |
90,324
-8,470
| -9% | -$1.99M | 0.38% | 47 |
|
2021
Q1 | $12.9M | Buy |
98,794
+25,539
| +35% | +$3.34M | 0.26% | 82 |
|
2020
Q4 | $7.65M | Sell |
73,255
-93
| -0.1% | -$9.72K | 0.16% | 135 |
|
2020
Q3 | $5.19M | Buy |
73,348
+4,298
| +6% | +$304K | 0.13% | 171 |
|
2020
Q2 | $4.43M | Buy |
69,050
+29,558
| +75% | +$1.9M | 0.11% | 198 |
|
2020
Q1 | $1.18M | Buy |
+39,492
| New | +$1.18M | 0.04% | 468 |
|